Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies
暂无分享,去创建一个
[1] C Crouzel,et al. PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] R. Frackowiak,et al. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke , 1992, The Lancet.
[3] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[4] N L Foster,et al. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET , 1995 .
[6] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[8] W. J. Lorenz,et al. Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .
[9] G Brix,et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Guy Marchal,et al. Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.
[11] R B Banati,et al. PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.
[12] Gerald Q. Maguire,et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. , 1997, Journal of computer assisted tomography.
[13] F E Turkheimer,et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis , 1999, Neurology.
[14] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[15] R B Banati,et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.
[16] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[17] R Tomczak,et al. In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.
[18] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[19] R B Banati,et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.
[20] Ronald Boellaard,et al. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET , 2001, European Journal of Nuclear Medicine.
[21] R B Banati,et al. Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. , 2001, AJR. American journal of roentgenology.
[22] S. Gunn,et al. Positron Emission Tomography Compartmental Models , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] R. Myers,et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.
[24] Eric Achten,et al. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. , 2002, Acta neurologica Belgica.
[25] O. Isacson,et al. Neuroinflammation of the nigrostriatal pathway during progressive 6‐OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging , 2002, The European journal of neuroscience.
[26] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[27] R B Banati,et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.
[28] Eric Achten,et al. Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.
[29] J Versijpt,et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.
[30] Tom Misteli,et al. In vivo imaging. , 2003, Methods.
[31] G. Glatting,et al. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.
[32] Elizabeth L Sampson,et al. In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.
[33] Alexander Gerhard,et al. In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.
[34] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[35] S. Wisniewski,et al. PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. , 2004, The Journal of clinical investigation.
[36] E. Yoshikawa,et al. Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.
[37] Alexander Gerhard,et al. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.
[38] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] R B Banati,et al. Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[40] J. Korf,et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study , 2005, Multiple sclerosis.
[41] Alexander Gerhard,et al. In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in progressive supranuclear palsy , 2006, Movement disorders : official journal of the Movement Disorder Society.